Healthcare · NYSE/NASDAQ: IDXX
IDEXX LABORATORIES INC /DE
Diagnostics & Research
Market Cap $44.96B
Verdict: Exceptional
Quality Scores
Multi-Bagger
88/100
Compounder Quality
96/100
Management Credibility
97/100
Governance
94/100
Cash Flow Quality
96/100
AI Summary
IDEXX Laboratories presents a masterclass in compounding within the resilient veterinary diagnostics and software ecosystem. The company has evolved from a mid-cap player into a dominant global force, characterized by a transition from millions to billions in revenue. Its business model is fortified by high-margin recurring revenue from diagnostic consumables and laboratory services. Over the last decade, operations have scaled significantly, with net income growing roughly 20x from 2016 to 2025. This growth is underpinned by secular trends in pet humanization and advanced veterinary care.…
Top Opportunities
- Secular tailwinds in companion animal healthcare
- High recurring revenue from diagnostic consumables
- Expansion of operating margins over 1,000bps in 10 years
Top Risks
- Negative equity history indicates aggressive financial engineering
- Valuation often trades at a significant premium to peers
- Sensitivity to vet clinic visit volumes
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.